Sanofi SA
NASDAQ:SNY

Watchlist Manager
Sanofi SA Logo
Sanofi SA
NASDAQ:SNY
Watchlist
Price: 48.74 USD 0.81% Market Closed
Market Cap: 121.8B USD

Intrinsic Value

The intrinsic value of one SNY stock under the Base Case scenario is 93.48 USD. Compared to the current market price of 48.74 USD, Sanofi SA is Undervalued by 48%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SNY Intrinsic Value
93.48 USD
Undervaluation 48%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Sanofi SA

What is Valuation History?
Ask AI Assistant
What other research platforms think about SNY?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is SNY valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Sanofi SA.

Explain Valuation
Compare SNY to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SAN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sanofi SA

Current Assets 34B
Cash & Short-Term Investments 8.9B
Receivables 497m
Other Current Assets 24.6B
Non-Current Assets 95.8B
PP&E 11.2B
Intangibles 68.9B
Other Non-Current Assets 15.7B
Current Liabilities 32.1B
Accounts Payable 22B
Other Current Liabilities 10.1B
Non-Current Liabilities 24.4B
Long-Term Debt 13.3B
Other Non-Current Liabilities 11.2B
Efficiency

Free Cash Flow Analysis
Sanofi SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sanofi SA

Revenue
66.9B EUR
Cost of Revenue
-18.5B EUR
Gross Profit
48.4B EUR
Operating Expenses
-32.6B EUR
Operating Income
15.8B EUR
Other Expenses
-2B EUR
Net Income
13.8B EUR
Fundamental Scores

SNY Profitability Score
Profitability Due Diligence

Sanofi SA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Healthy Operating Margin
ROE is Increasing
57/100
Profitability
Score

Sanofi SA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

SNY Solvency Score
Solvency Due Diligence

Sanofi SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Positive Net Debt
Short-Term Solvency
45/100
Solvency
Score

Sanofi SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SNY Price Targets Summary
Sanofi SA

Wall Street analysts forecast SNY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNY is 62.25 USD with a low forecast of 56.12 USD and a high forecast of 73.08 USD.

Lowest
Price Target
56.12 USD
15% Upside
Average
Price Target
62.25 USD
28% Upside
Highest
Price Target
73.08 USD
50% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SAN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

SAN Insider Trading
Buy and sell transactions by insiders

SNY News

Other Videos
What is the Intrinsic Value of one SNY stock?

The intrinsic value of one SNY stock under the Base Case scenario is 93.48 USD.

Is SNY stock undervalued or overvalued?

Compared to the current market price of 48.74 USD, Sanofi SA is Undervalued by 48%.

Back to Top